(Q49610748)

21 February 2018

title

Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L. (English)

1 reference

21 February 2018

author name string

Pedro Weslley Rosario

series ordinal

1

1 reference

21 February 2018

Maria Regina Calsolari

series ordinal

2

1 reference

21 February 2018

publication date

18 September 2017

1 reference

21 February 2018

Archives of endocrinology and metabolism

published in

1 reference

21 February 2018

volume

61

1 reference

21 February 2018

issue

5

1 reference

21 February 2018

page(s)

426-431

1 reference

21 February 2018

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update

cites work

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

The changing face of acromegaly--advances in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Acromegaly: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Laboratory investigation of acromegaly: is basal or random GH > 0.4 µg/L in the presence of normal serum IGF-1 an important result?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Acromegaly without imaging evidence of pituitary adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Medical progress: Acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Current diagnosis of acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

French consensus on the management of acromegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Screening for acromegaly in adult patients not reporting enlargement of the extremities, but with arterial hypertension associated with another comorbidity of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Arthropathy in acromegaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Evaluation of Variables Influencing the Measurement of Insulin-like Growth Factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Heterophilic antibodies may be a cause of falsely low total IGF1 levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Growth hormone after oral glucose overload: revision of reference values in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

Pituitary incidentaloma: an endocrine society clinical practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F2359-3997000000295

10.1590/2359-3997000000295

21 January 2018

Identifiers

DOI

1 reference

21 February 2018

PubMed ID

28977166

1 reference

21 February 2018